Form 8-K - Current report:
SEC Accession No. 0001104659-25-025055
Filing Date
2025-03-18
Accepted
2025-03-18 16:25:20
Documents
17
Period of Report
2025-03-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm259429d2_8k.htm   iXBRL 8-K 32394
2 EXHIBIT 1.1 tm259429d2_ex1-1.htm EX-1.1 217622
3 EXHIBIT 5.1 tm259429d2_ex5-1.htm EX-5.1 11142
7 GRAPHIC tm259429d2_ex5-1img001.jpg GRAPHIC 3138
8 GRAPHIC tm259429d2_ex5-1img002.jpg GRAPHIC 3717
  Complete submission text file 0001104659-25-025055.txt   511577

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mist-20250318.xsd EX-101.SCH 3036
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mist-20250318_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mist-20250318_pre.xml EX-101.PRE 22373
20 EXTRACTED XBRL INSTANCE DOCUMENT tm259429d2_8k_htm.xml XML 3816
Mailing Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6
Business Address 1111 BOUL. DR.-FREDERIK-PHILIPS, STE 420 MONTREAL A8 H4M 2X6 (514) 336-0444
Milestone Pharmaceuticals Inc. (Filer) CIK: 0001408443 (see all company filings)

EIN.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38899 | Film No.: 25748758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)